What is the primary goal of pharmacovigilance?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

What is the primary goal of pharmacovigilance?

The main aim of pharmacovigilance is to improve patient safety and ensure the safe use of medicines. This field focuses on detecting and evaluating adverse drug reactions, monitoring safety signals as drugs are used in the real world, and taking action to minimize risks—such as updating labeling, issuing warnings, or implementing risk management plans. The idea is to keep benefits outweighing risks for patients, throughout a medicine’s life cycle, by learning from real-world experiences and promptly addressing any safety concerns. Accelerating drug approval isn’t the focus here; pharmacovigilance deals with what happens after a drug is on the market and how safety is managed. Reducing clinical trial costs isn’t the primary goal, and safety work in pharmacovigilance often adds to the process rather than cutting costs. Increasing medication dosing would undermine safety objectives, which pharmacovigilance aims to prevent, not promote.

The main aim of pharmacovigilance is to improve patient safety and ensure the safe use of medicines. This field focuses on detecting and evaluating adverse drug reactions, monitoring safety signals as drugs are used in the real world, and taking action to minimize risks—such as updating labeling, issuing warnings, or implementing risk management plans. The idea is to keep benefits outweighing risks for patients, throughout a medicine’s life cycle, by learning from real-world experiences and promptly addressing any safety concerns.

Accelerating drug approval isn’t the focus here; pharmacovigilance deals with what happens after a drug is on the market and how safety is managed. Reducing clinical trial costs isn’t the primary goal, and safety work in pharmacovigilance often adds to the process rather than cutting costs. Increasing medication dosing would undermine safety objectives, which pharmacovigilance aims to prevent, not promote.

More practice questions